2006The company was established in 2006.
2010In 2010, the company invested 15 million yuan to build an API production workshop.
2013Obtained the 2010 GMP certificate for the first time in June 2013.
2019In 2019, naphazoline hydrochloride and Esomeprazole sodium were successfully associated with the formulation.
2022In 2022, Jinling Pharmaceutical Co., Ltd., a large state-owned listed company, was introduced as the controlling shareholder.
2023The company's official website was successfully revised in 2023.
